Close Menu

influenza

The Focus Diagnostics Simplexa Flu A/B & RSV test is intended to aid in the detection and discrimination of influenza A, influenza B, and respiratory syncytial virus infections.

GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.

The firm has licensed the new signatures that it said provide enhanced sensitivity and specificity for H1N1 specimens.

In a research paper published online this week, the scientists demonstrated that Cepheid's Xpert Flu A panel test represents "a great improvement" over methods currently employed by a majority of clinical labs to detect 2009 H1N1 influenza, but still falls a bit short when compared to the gold standard method.

The new venture also will work with Novartis on accelerating the production of influenza seed strains required for vaccine manufacturing.

Focus and 3M are also developing a version of the influenza A/B/RSV test, as well as a test for herpes simplex virus, that would be suitable for use in moderate-complexity laboratories under the Clinical Laboratory Improvement Amendments act.

The company is developing and validating assays for difficult-to-treat and drug-resistant infectious diseases based primarily on targets, biomarkers, and PCR primers developed at the Translational Genomics Research Institute and Northern Arizona University.

Gen-Probe's Prodesse ProFast+ flu assay; Diatherix's STD and herpes diagnostic panels; Mira Dx's PreOvar test for ovarian cancer risk; Seegene's MagicPlex Sepsis and Anyplex MDR-TB assays.

Gen-Probe said the assay is the only FDA-cleared molecular diagnostic test that can simultaneously detect seasonal A/H1, seasonal A/H3, and 2009 H1N1.

A number of molecular diagnostic tests that were cleared for emergency use during the 2009 H1N1 influenza pandemic will have to seek full FDA clearance now that HHS has declared the emergency over.

Pages

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.

Noel Rose, the "father of autoimmunity," has died at 92, the Washington Post reports.

According to CNN, Legionella was discovered in buildings leased by the Centers for Disease Control and Prevention as they reopened following coronavirus pandemic-related closures.

In PLOS this week: genetic analysis of malaria parasite populations in Southeast Asia, genomic surveillance of yellow fever virus in São Paulo, and more.